Sinergium Biotech is leading the new project to develop mRNA vaccines for avian influenza (H5N1)

Daily Current Affairs / Sinergium Biotech is leading the new project to develop mRNA vaccines for avian influenza (H5N1)

Change Language English Hindi

Category : Science and Tech Published on: August 02 2024

Share on facebook

Sinergium Biotech, supported by WHO and MPP, is leading an initiative to develop mRNA vaccines for avian influenza (H5N1), aiming to enhance pandemic preparedness in low- and middle-income
The project will focus on preclinical development and intends to share technology and expertise worldwide, promoting equitable access and fostering international collaboration.

Sudarshan Venu appointed Chairman and MD of TVS Motor effective August 25, 2025.
Read More....
Flipkart gets RBI nod to lend directly to customers and sellers via NBFC licence.
Read More....
Sara Errani and Andrea Vavassori win French Open 2025 mixed doubles title.
Read More....
Census 2027 to include caste data, will be held in two phases across India.
Read More....
Khichan and Menar wetlands in Rajasthan designated as new Ramsar sites.
Read More....
MoSPI releases 'EnviStats India 2025' on World Environment Day.
Read More....
S Mahendra Dev appointed as new Chairman of Economic Advisory Council to PM.
Read More....
Kumar Mangalam Birla receives USISPF Global Leadership Award 2025.
Read More....
Central Bank of India buys stake in Future Generali worth ₹451 crore.
Read More....
Government launches ‘Ayush Nivesh Saarthi’ portal to boost investment in traditional medicine.
Read More....

Sinergium Biotech is leading the new project to develop mRNA vaccines for avian influenza (H5N1)